Author Correction: Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells (Nature Communications, (2014), 5, 1, (4430), 10.1038/ncomms5430);Role of astroglia in down's syndrome revealed by patient-derived human-induced pluripotent stem cells

Nature Communications

Volumn 5, Issue , 2014, Pages

  Chen, Chen ^a,b,c   Jiang, Peng ^a,b   Xue, Haipeng ^d,e,f,g   Peterson, Suzanne E ^g   Tran, Ha T ^g   McCann, Anna E ^g,i   Parast, Mana M ^h   Li, Shenglan ^d,e   Pleasure, David E ^b   Laurent, Louise C ^f,g   Loring, Jeanne F ^f,g   Liu, Ying ^d,e,f,g   Deng, Wenbin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^c Tianjin Children's Hospital   (China)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MINOCYCLINE; THROMBOSPONDIN 1; THROMBOSPONDIN 2; CONDITIONED MEDIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMEODOMAIN PROTEIN; NOS2 PROTEIN, HUMAN; PROTEIN S100B; RAG-1 PROTEIN; S100B PROTEIN, HUMAN; THROMBOSPONDIN;

CHROMOSOME; CYTOLOGY; DRUG; GENE EXPRESSION; MOLECULAR ANALYSIS; NEUROLOGY; PATHOGENICITY;

ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOWN SYNDROME; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MACROGLIA; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE; PLURIPOTENT STEM CELL; SYNAPSE; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MUTANT MOUSE STRAIN; NEURAL STEM CELL; PATHOPHYSIOLOGY; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; ASTROCYTES; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CULTURE MEDIA, CONDITIONED; DOWN SYNDROME; GENE EXPRESSION PROFILING; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MINOCYCLINE; NEURAL STEM CELLS; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; THROMBOSPONDIN 1; THROMBOSPONDINS;

EID: 84904705701     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-020-14865-1     Document Type: Erratum

References (70)

1. Guidi, S. et al. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 18, 180-197 (2008). (Pubitemid 351430398)
2. Wisniewski, K. E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. 7, 274-281 (1990).
3. Busciglio, J. & Yankner, B. A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779 (1995). (Pubitemid 26004408)
4. Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J. & Mobley, W. C. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J. Comp. Neurol. 504, 329-345 (2007). (Pubitemid 47437199)
5. Esposito, G. et al. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum. Mol. Genet. 17, 440-457 (2008).
6. Oberheim, N. A. et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 29, 3276-3287 (2009).
7. Briggs, J. A. et al. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells 31, 467-478 (2013).
8. Shi, Y. et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci. Transl. Med. 4, 124ra129 (2012).
9. Weick, J. P. et al. Deficits in human trisomy 21 iPSCs and neurons. Proc. Natl Acad. Sci. USA 110, 9962-9967 (2013).
10. Jiang, J. et al. Translating dosage compensation to trisomy 21. Nature 500, 296-300 (2013).
11. Allaman, I. et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci. 30, 3326-3338 (2010).
12. Ballas, N., Lioy, D. T., Grunseich, C. & Mandel, G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12, 311-317 (2009).
13. Haidet-Phillips, A. M. et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824-828 (2011).
14. Jacobs, S., Nathwani, M. & Doering, L. C. Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci. 11, 132 (2010).
15. Marchetto, M. C. et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649-657 (2008).
16. Ullian, E. M., Sapperstein, S. K., Christopherson, K. S. & Barres, B. A. Control of synapse number by glia. Science 291, 657-661 (2001). (Pubitemid 32150425)
17. Clarke, L. E. & Barres, B. A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 14, 311-321 (2013).
18. Giordano, G., Pizzurro, D., VanDeMark, K., Guizzetti, M. & Costa, L. G. Manganese inhibits the ability of astrocytes to promote neuronal differentiation. Toxicol. Appl. Pharmacol. 240, 226-235 (2009).
19. Plane, J. M., Shen, Y., Pleasure, D. E. & Deng, W. Prospects for minocycline neuroprotection. Arch. Neurol. 67, 1442-1448 (2010).
20. Muller, F. J. et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8, 315-317 (2011).
21. Jiang, P. et al. hESC-derived Olig2(\+) progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury. Nat. Commun. 4, 2196 (2013).
22. Liu, Y. et al. CD44 expression identifies astrocyte-restricted precursor cells. Dev. Biol. 276, 31-46 (2004). (Pubitemid 39452844)
23. Dahl, D., Rueger, D. C., Bignami, A., Weber, K. & Osborn, M. Vimentin, the 57 000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur. J. Cell Biol. 24, 191-196 (1981). (Pubitemid 11009494)
24. Bahn, S. et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359, 310-315 (2002). (Pubitemid 34119295)
25. Lockrow, J. P., Fortress, A. M. & Granholm, A. C. Age-related neurodegeneration and memory loss in down syndrome. Curr. Gerontol. Geriatr. Res. 2012, 463909 (2012).
26. Hu, J., Castets, F., Guevara, J. L. & Van Eldik, L. J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271, 2543-2547 (1996).
27. Gupta, K. et al. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ. 19, 779-787 (2012).
28. Kraft, A. D., Johnson, D. A. & Johnson, J. A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci. 24, 1101-1112 (2004). (Pubitemid 38177017)
29. Christopherson, K. S. et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421-433 (2005). (Pubitemid 40222435)
30. Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107, 4335-4340 (2010).
31. Allen, N. J. et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410-414 (2012).
32. Lu, Z. & Kipnis, J. Thrombospondin 1-a key astrocyte-derived neurogenic factor. FASEB J. 24, 1925-1934 (2010).
33. Smith, G. M., Rutishauser, U., Silver, J. & Miller, R. H. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev. Biol. 138, 377-390 (1990).
34. Smith-Thomas, L. C. et al. An inhibitor of neurite outgrowth produced by astrocytes. J. Cell Sci. 107(Pt 6): 1687-1695 (1994). (Pubitemid 24198487)
35. Lu, J. et al. S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors. PloS ONE 6, e22126 (2011).
36. Hu, J., Ferreira, A. & Van Eldik, L. J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69, 2294-2301 (1997). (Pubitemid 27495414)
37. Johnson, M. A., Weick, J. P., Pearce, R. A. & Zhang, S. C. Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci. 27, 3069-3077 (2007). (Pubitemid 46474121)
38. Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622 (2007). (Pubitemid 46652435)
39. Kim, J. E. et al. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc. Natl Acad. Sci. USA 108, 3005-3010 (2011).
40. Ge, W. P., Zhou, W., Luo, Q., Jan, L. Y. & Jan, Y. N. Dividing glial cells maintain differentiated properties including complex morphology and functional synapses. Proc. Natl Acad. Sci. USA 106, 328-333 (2009).
41. Gomez-Casati, M. E. et al. Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression. Proc. Natl Acad. Sci. USA 107, 17005-17010 (2010).
42. Mauch, D. H. et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357 (2001). (Pubitemid 33063104)
43. Goritz, C., Mauch, D. H. & Pfrieger, F. W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 29, 190-201 (2005). (Pubitemid 40725610)
44. Xu, J., Xiao, N. & Xia, J. Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat. Neurosci. 13, 22-24 (2010).
45. D'Alessandro, J. S., Yetz-Aldape, J. &Wang, E. A. Bone morphogenetic proteins induce differentiation in astrocyte lineage cells. Growth Factors 11, 53-69 (1994). (Pubitemid 24310378)
46. Gross, R. E. et al. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17, 595-606 (1996). (Pubitemid 26365340)
47. Maclean, G. A. et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc. Natl Acad. Sci. USA 109, 17567-17572 (2012).
48. Han, X. et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 12, 342-353 (2013).
49. Jorgensen, O. S., Brooksbank, B. W. & Balazs, R. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J. Neurol. Sci. 98, 63-79 (1990). (Pubitemid 20262006)
50. Whitaker-Azmitia, P. M. et al. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776, 51-60 (1997). (Pubitemid 28018457)
51. Bradford, J. et al. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J. Biol. Chem. 285, 10653-10661 (2010).
52. Chen, P. C. et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl Acad. Sci. USA 106, 2933-2938 (2009).
53. Hughes, E. G., Elmariah, S. B. & Balice-Gordon, R. J. Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis. Mol. Cell. Neurosci. 43, 136-145 (2010).
54. Guizzetti, M., Moore, N. H., Giordano, G. & Costa, L. G. Modulation of neuritogenesis by astrocyte muscarinic receptors. J. Biol. Chem. 283, 31884-31897 (2008).
55. DeFreitas, M. F. et al. Identification of integrin alpha 3 beta 1 as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron 15, 333-343 (1995).
56. Neugebauer, K. M., Emmett, C. J., Venstrom, K. A. & Reichardt, L. F. Vitronectin and thrombospondin promote retinal neurite outgrowth: developmental regulation and role of integrins. Neuron 6, 345-358 (1991).
57. Liu, Y., Jiang, P. & Deng, W. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat. Protoc. 6, 640-655 (2011).
58. Hunter, C. L., Bachman, D. & Granholm, A. C. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann. Neurol. 56, 675-688 (2004). (Pubitemid 39540748)
59. Patterson, M. et al. Defining the nature of human pluripotent stem cell progeny. Cell Res. 22, 178-193 (2012).
60. Leigh, M. J. et al. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J. Dev. Behav. Pediatr. 34, 147-155 (2013).
61. Seidl, R. et al. Evidence for apoptosis in the fetal Down syndrome brain. J. Child Neurol. 16, 438-442 (2001). (Pubitemid 32631741)
62. Peterson, S. E. et al. Teratoma generation in the testis capsule. J. Vis. Exp. 57, e3177 (2011).
63. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T. & Yamaguchi, A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173-179 (2006). (Pubitemid 44387601)
64. Jiang, P. et al. Electrophysiological properties of human induced pluripotent stem cells. Am. J. Physiol. 298, C486-C495 (2010).
65. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001). (Pubitemid 34164012)
66. Campanelli, J. T. et al. Expression profiling of human glial precursors. BMC Dev. Biol. 8, 102 (2008).
67. Liu, Y. et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev. Biol. 6, 20 (2006).
68. Jiang, P. et al. Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells. Stem Cells 31(12): 2620-2631 (2013).
69. Zhu, S. et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74-78 (2002). (Pubitemid 34498818)
70. Wang, X. et al. Minocycline inhibits caspase-independent and-dependent mitochondrial cell death pathways in models of Huntington's disease. Proc. Natl Acad. Sci. USA 100, 10483-10487 (2003). (Pubitemid 37071904)